 Real-world evidence company Emerald Clinics ASX: EMD has hauled in a significant new client in the form of Spectrum Biomedical UK SBUK, the UK-based subsidiary of the worlds largest cannabis company Canopy Growth, to develop a real-world evidence RWE system in the UK. 